MannKind Corp. (MNKD)
3.58
+0.19
(+5.60%)
USD |
NASDAQ |
Jun 09, 16:00
3.58
0.00 (0.00%)
After-Hours: 19:21
MannKind SG&A Expense (Quarterly) : 108.17M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| United Therapeutics Corp. | 156.60M |
| ACADIA Pharmaceuticals, Inc. | 171.02M |
| Travere Therapeutics, Inc. | 105.07M |
| Agios Pharmaceuticals, Inc. | 48.30M |
| ADMA Biologics, Inc. | 27.80M |